Related Experiment Video

Updated: May 16, 2026

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
03:37

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

Global cerebral ischemia: synaptic and cognitive dysfunction

Jake T Neumann1, Charles H Cohan, Kunjan R Dave

  • 1Cerebral Vascular Disease Research Laboratories, Leonard M. Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Jneumann@med.miami.edu

Current Drug Targets
|November 23, 2012
PubMed

Insights

Global cerebral ischemia, often from cardiac arrest, causes brain damage. This review explores models, synaptic changes, and neuroprotection strategies, highlighting the need for broader approaches to improve cognitive function.

Area of Science:

  • Neuroscience
  • Cardiovascular Research

Background:

  • Cardiopulmonary arrest is a major cause of death and disability, particularly in older adults.
  • Global cerebral ischemia in animal models mimics neuronal damage seen after cardiac arrest, aiding research into neuroprotective agents.
  • Synaptic alterations due to excitotoxicity are a key focus, but current neuroprotective agents show limited clinical success.

Purpose of the Study:

  • To review various global cerebral ischemia models.
  • To examine synaptic alterations following global cerebral ischemia.
  • To discuss synaptic neuroprotection strategies and behavioral tests for cognitive assessment.

Main Methods:

  • Literature review of global cerebral ischemia models.
  • Analysis of synaptic changes and excitotoxicity mechanisms.
  • Evaluation of neuroprotective agents and cognitive assessment methods.

Main Results:

  • Existing neuroprotective agents targeting specific neuronal pathways have not significantly improved clinical outcomes.
  • Future neuroprotection may benefit from targeting non-specific pathways and addressing broader cognitive improvements.
  • Behavioral tests are crucial for evaluating functional deficits after global cerebral ischemia.

Conclusions:

  • Current neuroprotective strategies for global cerebral ischemia have limitations.
  • A shift towards non-specific targets and comprehensive cognitive enhancement is needed.
  • Further research into diverse models and assessment tools is essential for advancing neuroprotection.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...